Product Code: GVR-4-68040-419-4
Podiatry Chairs Market Size & Trends:
The global podiatry chairs market size was estimated at USD 1.1 billion in 2023 and is projected to grow at a CAGR of 7.4% over the forecast period. The increasing prevalence of foot disorders, technological advancements in podiatry chairs, rising demand for diabetic foot care, and the increased focus on foot health awareness are factors boosting market growth. According to an article published by AGS Health in Aging Foundation in February 2023, foot pain is a significant issue that can hinder mobility, leading to complications such as weight gain, muscle weakness, and weakening heart health. It's estimated that up to 87% of people experience foot pain at some point in their lives due to various causes. Among older adults, about one-third suffer from foot pain, stiffness, or aching feet.
Rising demand for diabetic foot care fuels the growth of the market. According to the American Medical Association article published in November 2023, diabetic foot ulcers are a common complication for individuals with type 1 or type 2 diabetes, affecting about one-third of diabetic patients over their lifetime. Globally, around 18.6 million people, including 1.6 million in the U.S. each year, suffer from these ulcers. With nearly half of these ulcers becoming infected and around 20% of those infections leading to partial or full foot amputations, the demand for specialized diabetic foot care is on the rise. This growing need is driving the market for podiatry chairs, as healthcare providers seek advanced equipment to effectively manage and treat diabetic foot conditions.
Adherence to recommended foot care practices is critical for individuals with diabetes. Yet studies have shown that many patients fall short in this area, leading to potentially severe complications. According to the NCBI article published in October 2023, research indicates that about 44.3% of diabetic individuals do not adequately follow the advised foot care routines. This lack of adherence can contribute to the development of serious issues such as infections, ulcers, and even amputations. The findings highlight a significant gap in the management of diabetic foot care, emphasizing the urgent need for continuous education and support. These aspects drive the demand for the podiatry chairs market.
Increased focus on foot health awareness drives the growth of the market. According to the Whittier Street Health Center article, April 2024 marks National Foot Health Awareness Month, an initiative by the American Podiatric Medical Association (AMPA) to emphasize the importance of maintaining good foot health. This campaign highlights that foot health is crucial for well-being and an active lifestyle. With growing awareness of the need for proper footwear and foot care practices, more people seek professional advice for foot-related issues. As awareness rises, the demand for podiatric services and equipment, such as specialized podiatry chairs, is expected to increase, driving market growth.
Global Podiatry Chairs Market Report Segmentation
This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global podiatry chairs market report on the basis of product, end use and region:
- Product Outlook (Revenue, USD Million, 2018 - 2030)
- Electric
- Manual
- End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Clinics
- Others
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
- Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. End Use
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity price analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product Segment
- 2.2.2. End Use Segment
- 2.2.3. Regional Outlook
- 2.3. Competitive Insights
Chapter 3. Global Podiatry Chairs Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.3. Podiatry Chairs Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
Chapter 4. Podiatry Chairs Market: Product Estimates & Trend Analysis
- 4.1. Podiatry Chairs Market: Product Dashboard
- 4.2. Podiatry Chairs Market: Product Movement Analysis
- 4.3. Podiatry Chairs Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Electric
- 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 4.5. Manual
- 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Podiatry Chairs Market: End Use Estimates & Trend Analysis
- 5.1. Podiatry Chairs Market: End Use Dashboard
- 5.2. Podiatry Chairs Market: End Use Movement Analysis
- 5.3. Podiatry Chairs Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 5.4. Hospitals
- 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.5. Clinics
- 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.6. Others
- 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Podiatry Chairs Market: Regional Estimates & Trend Analysis by Country, Product.
- 6.1. Global Podiatry Chairs Market: Regional Dashboard
- 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
- 6.3. North America
- 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.3.2. U.S.
- 6.3.2.1. Key country dynamics
- 6.3.2.2. Regulatory framework/ reimbursement structure
- 6.3.2.3. Competitive scenario
- 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.3. Canada
- 6.3.3.1. Key country dynamics
- 6.3.3.2. Regulatory framework/ reimbursement structure
- 6.3.3.3. Competitive scenario
- 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.4. Mexico
- 6.3.4.1. Key country dynamics
- 6.3.4.2. Regulatory framework/ reimbursement structure
- 6.3.4.3. Competitive scenario
- 6.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4. Europe
- 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.4.2. UK
- 6.4.2.1. Key country dynamics
- 6.4.2.2. Regulatory framework/ reimbursement structure
- 6.4.2.3. Competitive scenario
- 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.3. Germany
- 6.4.3.1. Key country dynamics
- 6.4.3.2. Regulatory framework/ reimbursement structure
- 6.4.3.3. Competitive scenario
- 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.4. France
- 6.4.4.1. Key country dynamics
- 6.4.4.2. Regulatory framework/ reimbursement structure
- 6.4.4.3. Competitive scenario
- 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.5. Italy
- 6.4.5.1. Key country dynamics
- 6.4.5.2. Regulatory framework/ reimbursement structure
- 6.4.5.3. Competitive scenario
- 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.6. Spain
- 6.4.6.1. Key country dynamics
- 6.4.6.2. Regulatory framework/ reimbursement structure
- 6.4.6.3. Competitive scenario
- 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.7. Sweden
- 6.4.7.1. Key country dynamics
- 6.4.7.2. Regulatory framework/ reimbursement structure
- 6.4.7.3. Competitive scenario
- 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.8. Norway
- 6.4.8.1. Key country dynamics
- 6.4.8.2. Regulatory framework/ reimbursement structure
- 6.4.8.3. Competitive scenario
- 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.9. Denmark
- 6.4.9.1. Key country dynamics
- 6.4.9.2. Regulatory framework/ reimbursement structure
- 6.4.9.3. Competitive scenario
- 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5. Asia Pacific
- 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.5.2. China
- 6.5.2.1. Key country dynamics
- 6.5.2.2. Regulatory framework/ reimbursement structure
- 6.5.2.3. Competitive scenario
- 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.3. Japan
- 6.5.3.1. Key country dynamics
- 6.5.3.2. Regulatory framework/ reimbursement structure
- 6.5.3.3. Competitive scenario
- 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.4. India
- 6.5.4.1. Key country dynamics
- 6.5.4.2. Regulatory framework/ reimbursement structure
- 6.5.4.3. Competitive scenario
- 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.5. Australia
- 6.5.5.1. Key country dynamics
- 6.5.5.2. Regulatory framework/ reimbursement structure
- 6.5.5.3. Competitive scenario
- 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.6. Thailand
- 6.5.6.1. Key country dynamics
- 6.5.6.2. Regulatory framework/ reimbursement structure
- 6.5.6.3. Competitive scenario
- 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.7. South Korea
- 6.5.7.1. Key country dynamics
- 6.5.7.2. Regulatory framework/ reimbursement structure
- 6.5.7.3. Competitive scenario
- 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
- 6.6. Latin America
- 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.6.2. Brazil
- 6.6.2.1. Key country dynamics
- 6.6.2.2. Regulatory framework/ reimbursement structure
- 6.6.2.3. Competitive scenario
- 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
- 6.6.3. Argentina
- 6.6.3.1. Key country dynamics
- 6.6.3.2. Regulatory framework/ reimbursement structure
- 6.6.3.3. Competitive scenario
- 6.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
- 6.7. MEA
- 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.7.2. Saudi Arabia
- 6.7.2.1. Key country dynamics
- 6.7.2.2. Regulatory framework/ reimbursement structure
- 6.7.2.3. Competitive scenario
- 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
- 6.7.3. South Africa
- 6.7.3.1. Key country dynamics
- 6.7.3.2. Regulatory framework/ reimbursement structure
- 6.7.3.3. Competitive scenario
- 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
- 6.7.4. UAE
- 6.7.4.1. Key country dynamics
- 6.7.4.2. Regulatory framework/ reimbursement structure
- 6.7.4.3. Competitive scenario
- 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
- 6.7.5. Kuwait
- 6.7.5.1. Key country dynamics
- 6.7.5.2. Regulatory framework/ reimbursement structure
- 6.7.5.3. Competitive scenario
- 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
- 7.2. Company/Competition Categorization
- 7.3. Vendor Landscape
- 7.3.1. List of key distributors and channel partners
- 7.3.2. Key company market share analysis, 2023
- 7.3.3. Angelus Medical and Optical
- 7.3.3.1. Company overview
- 7.3.3.2. Financial performance
- 7.3.3.3. Product benchmarking
- 7.3.3.4. Strategic initiatives
- 7.3.4. Medline
- 7.3.4.1. Company overview
- 7.3.4.2. Financial performance
- 7.3.4.3. Product benchmarking
- 7.3.4.4. Strategic initiatives
- 7.3.5. Midmark Corporation
- 7.3.5.1. Company overview
- 7.3.5.2. Financial performance
- 7.3.5.3. Product benchmarking
- 7.3.5.4. Strategic initiatives
- 7.3.6. Hill Laboratories
- 7.3.6.1. Company overview
- 7.3.6.2. Financial performance
- 7.3.6.3. Product benchmarking
- 7.3.6.4. Strategic initiatives
- 7.3.7. ARIA Chairs
- 7.3.7.1. Company overview
- 7.3.7.2. Financial performance
- 7.3.7.3. Product benchmarking
- 7.3.7.4. Strategic initiatives
- 7.3.8. Soma Tech Intl.
- 7.3.8.1. Company overview
- 7.3.8.2. Financial performance
- 7.3.8.3. Product benchmarking
- 7.3.8.4. Strategic initiatives
- 7.3.9. Lemi MD
- 7.3.9.1. Company overview
- 7.3.9.2. Financial performance
- 7.3.9.3. Product benchmarking
- 7.3.9.4. Strategic initiatives
- 7.3.10. Gharieni Group
- 7.3.10.1. Company overview
- 7.3.10.2. Financial performance
- 7.3.10.3. Product benchmarking
- 7.3.10.4. Strategic initiatives
- 7.3.11. TitanMed
- 7.3.11.1. Company overview
- 7.3.11.2. Financial performance
- 7.3.11.3. Product benchmarking
- 7.3.11.4. Strategic initiatives
- 7.3.12. Namrol Medical S.L.
- 7.3.12.1. Company overview
- 7.3.12.2. Financial performance
- 7.3.12.3. Product benchmarking
- 7.3.12.4. Strategic initiatives